CureMD at a glance
Vendor fundamentals lifted from public sources — CureMD's own product pages, SEC filings (where listed), and independent analyst coverage — so you can size the company against QuickIntell before comparing features.
| Dimension | QuickIntell | CureMD |
|---|---|---|
| Founded | 2023 | 1997 |
| Category positioning | AI-native RCM (autonomous coding, denial prediction, voice agents). | RCM, coding, prior auth, ERA / remits, ambient scribe, EHR capabilities. |
| Primary segments | Ambulatory practices, specialty groups, mid-market health systems, and RCM companies. | Ambulatory practices, Specialty practices, Small-to-mid hospitals |
| Typical customer | Ambulatory and mid-market groups that want AI-native RCM layered on their existing EHR without a full platform migration. | Independent ambulatory practices and small specialty groups (<25 providers) wanting an all-in-one EHR+PM+RCM contract at predictable per-provider pricing. |
| Public presence on RCM head queries | Programmatic payer/CARC/RARC/EHR/compare page network with SERP-informed templates. | Top-30 organic on 6 of 10 priority RCM head queries (DataForSEO, 2026-04-23). |
Feature matrix: QuickIntell vs CureMD
Feature flags reflect each vendor's public product positioning as of 2026-04-23. Marketplace modules, partnerships, or bespoke-services add-ons may expand either side's footprint — verify with current documentation before procurement.
| Capability | QuickIntell | CureMD |
|---|---|---|
| Pricing model | Published PMPM / PMPE tiers with module-based pricing. | Per-provider per-month subscription; separate RCM % of collections if bundled with services. |
| Typical customer | Ambulatory and mid-market groups wanting AI-native RCM on their existing EHR. | Independent ambulatory practices and small specialty groups (<25 providers) wanting an all-in-one EHR+PM+RCM contract at predictable per-provider pricing. |
| End-to-end RCM | Yes — QuickRCM covers eligibility, PA, coding, claims, ERA, AR. | Yes |
| Autonomous AI coding | Yes — QuickCode runs fully unattended on clean claims. | Coding tooling present; review intensity varies by deployment. |
| Prior-auth automation | Yes — QuickAuth covers 278, portal, and fax payer routes. | Yes |
| Electronic remits (ERA / 835) | Yes — QuickERA posts 835 remits and flags underpayments. | Yes |
| Ambient clinical scribe | Yes — QuickScribe ambient documentation. | Yes |
| Voice agents | Yes — QuickVoice handles patient intake and payer IVR calls. | No |
| Is itself an EHR? | No — integrates with any EHR without migration. | Yes |
Where CureMD is strong
CureMD has earned real operational ground — the bullets below come from CureMD's own product pages, SEC filings where applicable, and independent analyst coverage rather than from QuickIntell marketing.
Integrated EHR + PM + RCM + scribe under one vendor contract — smaller practices avoid stitching 3–4 systems together.
ONC-certified EHR with MIPS/MACRA reporting baked in; Meaningful Use attestation support for ambulatory clinics.
Strong content SEO on ICD-10/CPT lookups drives inbound ambulatory-practice leads at low CAC.
Lower total-cost-of-ownership than enterprise suites for <25-provider groups.
Where CureMD has scope-of-fit gaps
These are scope-of-fit statements, not defect claims — the buyer view is "what does CureMD not attempt to solve?" so you can weigh whether that matters for your ICP.
Ambulatory-only focus; not a fit for multi-hospital systems or large inpatient EHR migration.
AI modules (scribe, coding) are newer and less battle-tested than pure-play AI vendors.
Support escalations rely on a shared pool rather than dedicated customer success for sub-enterprise accounts.
QuickIntell differentiators vs CureMD
The points below are specific to a QuickIntell vs CureMD matchup — they surface where QuickIntell's architecture or pricing model materially changes the outcome versus staying on CureMD.
QuickIntell is RCM/AI-native; providers keep their preferred EHR instead of migrating to CureMD's clinical platform.
QuickIntell's autonomous coding reaches fully-unattended for clean claims; CureMD's coding tools still require coder review.
QuickIntell's voice agent (QuickVoice) automates patient intake and payer calls; CureMD has no voice product.
QuickIntell publishes per-payer benchmarks; CureMD does not.
Pricing model comparison
Pricing is the single most-searched refinement on head-to-head RCM queries (`curemd vs quickintell cost`, `curemd pricing`). Neither vendor publishes a full price sheet publicly, so the summary below reflects each vendor's contracting posture rather than an SKU-level quote.
Published PMPM / PMPE tiers with module-based pricing (QuickRCM, QuickAuth, QuickCode, QuickERA, QuickVoice, QuickScribe). Groups can evaluate cost ranges before a formal RFP and contract per module rather than buying the entire suite.
Per-provider per-month subscription; separate RCM % of collections if bundled with services.
Customer fit: who each platform is built for
You want autonomous coding, denial prediction, voice agents, and an ambient scribe under one contract that integrates with your existing EHR. Ambulatory groups and mid-market health systems are the strongest fit — implementation runs in weeks rather than quarters and pricing is published PMPM / PMPE tiers.
Independent ambulatory practices and small specialty groups (<25 providers) wanting an all-in-one EHR+PM+RCM contract at predictable per-provider pricing. Integrated EHR + PM + RCM + scribe under one vendor contract — smaller practices avoid stitching 3–4 systems together.
CureMD is also the EHR. Most groups keep CureMD as the clinical system of record and layer QuickIntell for AI-native RCM automation (autonomous coding, denial prediction, voice agents) — QuickIntell's integration is bidirectional and does not require an EHR switch.
You are in-year on a multi-year CureMD contract with no material scope-of-fit gaps, you have a live implementation or optimization project underway, or the scope of your pain is a single workflow that CureMD already addresses.
Migrating from CureMD to QuickIntell
A full RCM platform switch is a multi-quarter project, not a weekend cutover. The sequence below surfaces contractual, data, and operational gates before they surprise you at go-live. QuickIntell's implementation team runs this playbook as part of every onboarding.
- 1Review your CureMD contract and exit clause
Pull the CureMD master services agreement and identify notice periods, data-retention guarantees, and any exit fees. Most RCM agreements require 60–180 days of written notice; do not commit to a QuickIntell go-live date before you have documented this window.
- 2Inventory integrations and data flows
Map every inbound and outbound connection from CureMD — EHR feeds, clearinghouse routing, payer SFTP accounts, bank reconciliation files, analytics exports. Each connection becomes a cutover task with its own credential, schema, and QA owner in the QuickIntell implementation plan.
- 3Export historical data
Request a full data export from CureMD while you are still under contract: claims, remits, patient-responsibility history, denial notes, appeal documentation, and fee-schedule history. QuickIntell ingests historical feeds during onboarding so denial-prediction models warm up with your payer-specific patterns on day one.
- 4Run QuickIntell in parallel for one claims cycle
Dual-submit a subset of claims through both CureMD and QuickIntell for at least one full month — ideally two month-ends. Reconcile remits and denial codes line-by-line. Parallel running is the single biggest predictor of a clean cutover; skipping it routinely produces a 15–25% AR bump in the first 60 days post go-live.
- 5Train staff and document the new playbook
Update SOPs, clearinghouse routing docs, denial-workflow runbooks, and month-end close checklists. QuickIntell's implementation team publishes a per-customer playbook covering edits, work queues, and terminology differences vs CureMD so the transition does not break muscle memory.
- 6Cut over in waves and keep CureMD read-only
Cut over by payer, specialty, or service line rather than flipping every claim in a single day. Keep CureMD accessible in read-only mode for 12 months post-migration so you can look up aged AR, pull historical EOBs, and respond to payer audits on claims submitted under the old system.
Frequently asked questions
Is QuickIntell a direct replacement for CureMD?
Not exactly — CureMD is an EHR as well as an RCM suite, and QuickIntell does not replace the clinical EHR. Groups on CureMD typically keep the EHR and layer QuickIntell for AI-native RCM automation, which is a scope expansion rather than a rip-and-replace.
Who are CureMD's main competitors?
CureMD's most-evaluated competitors include QuickIntell plus a shortlist that varies by organization size and EHR posture. Enterprise IDNs evaluate a different mix than mid-market physician groups, and Epic customers weight EHR-native RCM differently than groups on athena, eClinicalWorks, or Meditech. See our /alternatives/curemd page for a 6-criterion comparison against four independent alternatives.
Is CureMD a legitimate company?
Yes. CureMD was founded in 1997 and is actively operating as of 2026-04-23. Vendor public pages: https://www.curemd.com/. Evidence sources consulted for this comparison: CureMD product pages: https://www.curemd.com/; G2 CureMD: https://www.g2.com/products/curemd/reviews; Capterra CureMD reviews: https://www.capterra.com/p/60749/CureMD/.
What does CureMD cost compared with QuickIntell?
CureMD's published pricing model is "Per-provider per-month subscription; separate RCM % of collections if bundled with services.". Most enterprise-contracted RCM platforms do not publish price sheets, so buyers must request a formal quote. QuickIntell publishes PMPM / PMPE tiers per module so you can benchmark cost before an RFP — the transparency is the differentiator, not necessarily the line-item price.
Is CureMD a clearinghouse, an RCM platform, or an EHR?
CureMD is both an EHR and an RCM platform — clinical and financial functionality ships under the same contract. That is a fundamental difference versus QuickIntell, which is RCM-only and integrates with whichever EHR you already run.
How long does it take to switch from CureMD to QuickIntell?
A full RCM platform migration typically runs 4–9 months: 60–180 days of contract notice, 30–60 days of integration build and data export, one to two month-ends of parallel running, and a waved cutover. QuickIntell's implementation team publishes a per-customer playbook for each CureMD migration — the six-step checklist above is the public sequence.
Is this comparison independent?
This page is a QuickIntell publication. Every strength and limitation cited about CureMD is sourced from CureMD's own documentation, SEC filings (where applicable), and independent analyst coverage (CureMD product pages: https://www.curemd.com/; G2 CureMD: https://www.g2.com/products/curemd/reviews). Re-verify before any procurement decision — vendors update their positioning frequently and this page is reviewed on a 180-day cycle per our editorial SLA.
Editor's take
Long-form editorial analysis of the QuickIntell vs CureMD matchup from the QuickIntell editorial team. Structured data above is the authoritative source for feature, pricing, and fit decisions; the narrative below adds context and operator-level perspective.
Operator take: QuickIntell vs CureMD
CureMD and QuickIntell are rarely true head-to-head replacements. CureMD is an integrated ambulatory EHR + PM + RCM + scribe bundle aimed at independent practices under ~25 providers who want one vendor and predictable per-provider pricing. QuickIntell is an AI-native RCM platform that integrates into whichever EHR the practice already runs. The right question is almost never "which one replaces the other" — it is "which ICP matches yours."
Three scoping decisions drive the call:
- Do you want to migrate the EHR? Practices on athenaOne, eClinicalWorks, or a specialty EHR rarely gain enough from CureMD's bundle to justify clinical-workflow disruption. QuickIntell layers onto the existing EHR and keeps clinicians in their current documentation paths.
- Where does the AI need to run? CureMD has added AI scribing and ICD-lookup tooling, but autonomous coding on clean claims, denial prediction at scale, and voice agents for payer calls are not the flagship. QuickIntell ships all three as core product.
- Operational control. CureMD often couples RCM software with optional services; QuickIntell's RCM is operated by the customer's internal team with AI automation on top. Teams that want to consolidate vendors pick CureMD; teams that want AI-native automation on an existing EHR pick QuickIntell.
If the buying thesis is "one vendor for everything at a low per-provider rate," CureMD is the sharper pick. If it is "AI-native RCM layered on my current clinical stack," QuickIntell is.
See how QuickIntell replaces or complements CureMD
A 30-minute demo walks through QuickRCM, QuickAuth, QuickCode, and QuickERA against your current CureMD workflows — autonomous coding, denial prediction, and voice agents all included.
Disclaimer
This page is editorial reference for RCM buyers and is not affiliated with or endorsed by CureMD. Each vendor's name is a trademark of its owner. Product capabilities, pricing, and positioning change — verify against the vendor's current documentation before procurement. Primary source consulted for CureMD: CureMD product pages: https://www.curemd.com/.